- Antibiotic resistance ×
-
Farm management and antimicrobial resistance in Northern Ireland
August 4, 2021
In this blog, Katie, a third year PhD student in the Huws Lab at Queen’s University Belfast discusses her research into antimicrobial resistance in Northern Ireland and how this is influenced by farm management practices. Katie presented her research at the Microbiology Society’s Annual Conference Online 2021.
-
Exploring co-culturing to enhance antimicrobial compound production among isolates generated through the Antibiotics Unearthed Programme
January 27, 2021
Each year, the Microbiology Society awards a number of grants that enable undergraduates to work on microbiological research projects during the summer vacation and provide early- and mid-career scientists the opportunity to gain supervision experience. Over the next few months, we’ll be posting a series of blogs from members who were awarded Harry Smith Vacation Studentships in 2020. This week is lecturer Dr Niall O’Leary and undergraduate student Leah McPhillips from University College Cork.
-
New antibiotics needed: Pseudomonas aeruginosa
September 17, 2020
In 2017, the World Health Organization (WHO) published the ’12 Priority Pathogens’: a list of 12 microbes that are becoming increasingly resistant to current antimicrobials. These 12 pathogens are thought by WHO to pose the greatest threat to human health.
-
JMM Editor’s Choice: does sub-culturing of positive MRSA blood cultures affect vancomycin MICs?
September 7, 2020
The Journal of Medical Microbiology (JMM) is a journal published by the Microbiology Society, focused on providing comprehensive coverage of medical, dental and veterinary microbiology and infectious diseases, including bacteriology, virology, mycology and parasitology. This month, Dr Steve Michell discusses the paper ‘Does sub-culturing of positive MRSA blood cultures affect vancomycin MICs?’ which was chosen as Editor’s Choice for the August issue of JMM.
-
Antimicrobial resistance: the next pandemic?
August 26, 2020
It is now estimated 700,000 people die each year as a result of drug resistant diseases, with this number predicted to increase to over 10 million deaths per year by 2050. The current COVID-19 pandemic appears to have accelerated the threat of antimicrobial resistance (AMR), as many patients admitted to hospitals displaying COVID-19 symptoms are treated with antibiotics to reduce their chances of contracting secondary bacterial infections, making resistant bacteria more common.
-
New antibiotics needed: Helicobacter pylori
July 23, 2020
In 2017, the World Health Organization (WHO) published the ’12 Priority Pathogens’: a list of 12 microbes that are becoming increasingly resistant to current antimicrobials. These 12 pathogens are thought by WHO to pose the greatest threat to human health.
-
JMM Editor’s Choice: mechanisms of colistin resistance
May 15, 2020
The Journal of Medical Microbiology (JMM) is a journal published by the Microbiology Society, focused on providing comprehensive coverage of medical, dental and veterinary microbiology and infectious diseases, including bacteriology, virology, mycology and parasitology. This month, Dr Kim Hardie discusses the paper ‘Mutations in the two component regulator systems PmrAB and PhoPQ give rise to increased colistin resistance in Citrobacter and Enterobacter spp.’ which was selected as Editor’s Choice from the April issue of JMM.
-
Microbe Talk: Could snake venom contain antibiotics?
April 23, 2020
This month on Microbe Talk, Laura speaks with Alice Fraser from the Liverpool School of Tropical Medicine. Alice is part of a research team looking for new antibiotics in unexpected places. Listen to the episode to find out about her research searching for antibiotic proteins in snake venoms and find out what Alice has found so far.
